388 related articles for article (PubMed ID: 34168653)
41. Investigation of three potential autoantibodies in Sjogren's syndrome and associated MALT lymphoma.
Cui L; Elzakra N; Xu S; Xiao GG; Yang Y; Hu S
Oncotarget; 2017 May; 8(18):30039-30049. PubMed ID: 28404907
[TBL] [Abstract][Full Text] [Related]
42. CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjogren's syndrome and MALT lymphoma: association with reactive and malignant areas of lymphoid organization.
Barone F; Bombardieri M; Rosado MM; Morgan PR; Challacombe SJ; De Vita S; Carsetti R; Spencer J; Valesini G; Pitzalis C
J Immunol; 2008 Apr; 180(7):5130-40. PubMed ID: 18354239
[TBL] [Abstract][Full Text] [Related]
43. Co-culture system of human salivary gland epithelial cells and immune cells from primary Sjögren's syndrome patients: an in vitro approach to study the effects of Rituximab on the activation of the Raf-1/ERK1/2 pathway.
Lisi S; Sisto M; D'Amore M; Lofrumento DD
Int Immunol; 2015 Apr; 27(4):183-94. PubMed ID: 25381666
[TBL] [Abstract][Full Text] [Related]
44. B Cell Depletion Therapy Normalizes Circulating Follicular Th Cells in Primary Sjögren Syndrome.
Verstappen GM; Kroese FG; Meiners PM; Corneth OB; Huitema MG; Haacke EA; van der Vegt B; Arends S; Vissink A; Bootsma H; Abdulahad WH
J Rheumatol; 2017 Jan; 44(1):49-58. PubMed ID: 28042126
[TBL] [Abstract][Full Text] [Related]
45. Autoimmune hepatitis in primary Sjogren's syndrome: pathological study of the livers and labial salivary glands in 17 patients with primary Sjogren's syndrome.
Matsumoto T; Morizane T; Aoki Y; Yamasaki S; Nakajima M; Enomoto N; Kobayashi S; Hashimoto H
Pathol Int; 2005 Feb; 55(2):70-6. PubMed ID: 15693852
[TBL] [Abstract][Full Text] [Related]
46. The Role of Regulatory T Cells in the Onset and Progression of Primary Sjögren's Syndrome.
Blinova VG; Vasilyev VI; Rodionova EB; Zhdanov DD
Cells; 2023 May; 12(10):. PubMed ID: 37408193
[TBL] [Abstract][Full Text] [Related]
47. Low Protein A20 in Minor Salivary Glands is Associated with Lymphoma in Primary Sjögren's Syndrome.
Johnsen SJ; Gudlaugsson E; Skaland I; Janssen EA; Jonsson MV; Helgeland L; Berget E; Jonsson R; Omdal R
Scand J Immunol; 2016 Mar; 83(3):181-7. PubMed ID: 26679293
[TBL] [Abstract][Full Text] [Related]
48. B cells in Sjögren's syndrome: from pathophysiology to diagnosis and treatment.
Cornec D; Devauchelle-Pensec V; Tobón GJ; Pers JO; Jousse-Joulin S; Saraux A
J Autoimmun; 2012 Sep; 39(3):161-7. PubMed ID: 22749831
[TBL] [Abstract][Full Text] [Related]
49. CD4(-)CD8(-) T-cells in primary Sjögren's syndrome: association with the extent of glandular involvement.
Alunno A; Carubbi F; Bistoni O; Caterbi S; Bartoloni E; Bigerna B; Pacini R; Beghelli D; Cipriani P; Giacomelli R; Gerli R
J Autoimmun; 2014 Jun; 51():38-43. PubMed ID: 24461537
[TBL] [Abstract][Full Text] [Related]
50. LncRNA Neat1 positively regulates MAPK signaling and is involved in the pathogenesis of Sjögren's syndrome.
Ye L; Shi H; Yu C; Fu J; Chen C; Wu S; Zhan T; Wang B; Zheng L
Int Immunopharmacol; 2020 Nov; 88():106992. PubMed ID: 33182021
[TBL] [Abstract][Full Text] [Related]
51. The T cell in Sjogren's syndrome: force majeure, not spectateur.
Singh N; Cohen PL
J Autoimmun; 2012 Sep; 39(3):229-33. PubMed ID: 22709856
[TBL] [Abstract][Full Text] [Related]
52. Ectopic lymphoid neogenesis and lymphoid chemokines in Sjogren's syndrome: at the interplay between chronic inflammation, autoimmunity and lymphomagenesis.
Bombardieri M; Pitzalis C
Curr Pharm Biotechnol; 2012 Aug; 13(10):1989-96. PubMed ID: 22208651
[TBL] [Abstract][Full Text] [Related]
53. Mucosa-associated lymphoid tissue lymphoma in Sjögren's syndrome: risks, management, and prognosis.
Voulgarelis M; Moutsopoulos HM
Rheum Dis Clin North Am; 2008 Nov; 34(4):921-33, viii. PubMed ID: 18984412
[TBL] [Abstract][Full Text] [Related]
54. IL-2 Inhibition of Th17 Generation Rather Than Induction of Treg Cells Is Impaired in Primary Sjögren's Syndrome Patients.
Luo J; Ming B; Zhang C; Deng X; Li P; Wei Z; Xia Y; Jiang K; Ye H; Ma W; Liu Z; Li H; Yang XP; Dong L
Front Immunol; 2018; 9():1755. PubMed ID: 30150979
[TBL] [Abstract][Full Text] [Related]
55. Telocytes in minor salivary glands of primary Sjögren's syndrome: association with the extent of inflammation and ectopic lymphoid neogenesis.
Alunno A; Ibba-Manneschi L; Bistoni O; Rosa I; Caterbi S; Gerli R; Manetti M
J Cell Mol Med; 2015 Jul; 19(7):1689-96. PubMed ID: 25753463
[TBL] [Abstract][Full Text] [Related]
56. Type I interferons in Sjögren's syndrome.
Yao Y; Liu Z; Jallal B; Shen N; Rönnblom L
Autoimmun Rev; 2013 Mar; 12(5):558-66. PubMed ID: 23201923
[TBL] [Abstract][Full Text] [Related]
57. Primary Sjögren's syndrome: oral aspects on pathogenesis, diagnostic criteria, clinical features and approaches for therapy.
Pedersen AM; Nauntofte B
Expert Opin Pharmacother; 2001 Sep; 2(9):1415-36. PubMed ID: 11585021
[TBL] [Abstract][Full Text] [Related]
58. A role for lymphotoxin in primary Sjogren's disease.
Shen L; Suresh L; Wu J; Xuan J; Li H; Zhang C; Pankewycz O; Ambrus JL
J Immunol; 2010 Nov; 185(10):6355-63. PubMed ID: 20952683
[TBL] [Abstract][Full Text] [Related]
59. Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjögren's syndrome.
Salomonsson S; Larsson P; Tengnér P; Mellquist E; Hjelmström P; Wahren-Herlenius M
Scand J Immunol; 2002 Apr; 55(4):336-42. PubMed ID: 11967114
[TBL] [Abstract][Full Text] [Related]
60. Association of plasmacytoid dendritic cells with B cell infiltration in minor salivary glands in patients with Sjögren's syndrome.
Zhao J; Kubo S; Nakayamada S; Shimajiri S; Zhang X; Yamaoka K; Tanaka Y
Mod Rheumatol; 2016 Sep; 26(5):716-24. PubMed ID: 26706891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
